Clinical Trial Update: A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults [Phase 1, Phase 2]

View source ↗

Summary

A Pfizer-sponsored Phase 1/2 clinical trial to assess safety and immune response of a new pneumococcal vaccine in adults, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Pfizer pneumococcal vaccine (investigational)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING